FI90658B - Förfarande för framställning av terapeutiskt användbar (E)-2-(p-fluorfenetyl)-3-fluorallylamin - Google Patents

Förfarande för framställning av terapeutiskt användbar (E)-2-(p-fluorfenetyl)-3-fluorallylamin Download PDF

Info

Publication number
FI90658B
FI90658B FI882836A FI882836A FI90658B FI 90658 B FI90658 B FI 90658B FI 882836 A FI882836 A FI 882836A FI 882836 A FI882836 A FI 882836A FI 90658 B FI90658 B FI 90658B
Authority
FI
Finland
Prior art keywords
fluorophenethyl
fluoroallylamine
ester
mao
acid
Prior art date
Application number
FI882836A
Other languages
English (en)
Finnish (fi)
Other versions
FI90658C (sv
FI882836A0 (sv
FI882836A (sv
Inventor
Ian A Mcdonald
Michael G Palfreyman
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI882836A0 publication Critical patent/FI882836A0/sv
Publication of FI882836A publication Critical patent/FI882836A/sv
Application granted granted Critical
Publication of FI90658B publication Critical patent/FI90658B/sv
Publication of FI90658C publication Critical patent/FI90658C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/29—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI882836A 1987-06-16 1988-06-14 Förfarande för framställning av terapeutiskt användbar (E)-2-(p-fluorfenetyl)-3-fluorallylamin FI90658C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6275887A 1987-06-16 1987-06-16
US6275887 1987-06-16

Publications (4)

Publication Number Publication Date
FI882836A0 FI882836A0 (sv) 1988-06-14
FI882836A FI882836A (sv) 1988-12-17
FI90658B true FI90658B (sv) 1993-11-30
FI90658C FI90658C (sv) 1994-03-10

Family

ID=22044602

Family Applications (1)

Application Number Title Priority Date Filing Date
FI882836A FI90658C (sv) 1987-06-16 1988-06-14 Förfarande för framställning av terapeutiskt användbar (E)-2-(p-fluorfenetyl)-3-fluorallylamin

Country Status (16)

Country Link
EP (1) EP0295604A1 (sv)
JP (1) JP2511293B2 (sv)
KR (1) KR970000142B1 (sv)
CN (1) CN1031075A (sv)
AR (1) AR243493A1 (sv)
AU (1) AU612655B2 (sv)
CA (1) CA1335897C (sv)
DK (1) DK325788A (sv)
FI (1) FI90658C (sv)
HU (1) HU202823B (sv)
IL (1) IL86746A0 (sv)
NO (1) NO167381C (sv)
NZ (1) NZ224982A (sv)
PH (1) PH24012A (sv)
PT (1) PT87732B (sv)
ZA (1) ZA884183B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023023A1 (en) * 1992-05-15 1993-11-25 University Of Saskatchewan Method for preventing endothelium damage in mammals and for alleviating pain associated with gout and arthritis
ATE147978T1 (de) * 1992-05-27 1997-02-15 Merrell Pharma Inc Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
US5599986A (en) * 1994-09-29 1997-02-04 Hoechst Marion Roussel Inc. Process for the preparation of alkali metal salts of diformylamide
US5488188A (en) * 1994-09-29 1996-01-30 Merrell Dow Pharmaceuticals Inc. Process for the preparation of (E)-1-amino-2-(fluoromethylene)-4-(p-fluorophenyl)butane, novel processes for preparing an intermediate thereof, and novel intermediates thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454158A (en) * 1981-06-01 1984-06-12 Merrell Toraude Et Compagnie Allyl amine MAO inhibitors
JPH0660132B2 (ja) * 1985-12-05 1994-08-10 メレルダウフア−マス−テイカルズ インコ−ポレ−テツド 非芳香族フルオロアリルアミンｍａｏ阻害剤

Also Published As

Publication number Publication date
CA1335897C (en) 1995-06-13
KR890000399A (ko) 1989-03-14
HU202823B (en) 1991-04-29
DK325788A (da) 1988-12-17
AU1762988A (en) 1988-12-22
PT87732B (pt) 1992-10-30
IL86746A0 (en) 1988-11-30
EP0295604A1 (en) 1988-12-21
AU612655B2 (en) 1991-07-18
PT87732A (pt) 1988-07-01
AR243493A1 (es) 1993-08-31
DK325788D0 (da) 1988-06-15
ZA884183B (en) 1989-02-22
NO167381C (no) 1991-10-30
NO882655L (no) 1988-12-19
FI90658C (sv) 1994-03-10
NZ224982A (en) 1990-08-28
CN1031075A (zh) 1989-02-15
NO882655D0 (no) 1988-06-15
KR970000142B1 (ko) 1997-01-04
FI882836A0 (sv) 1988-06-14
JPS6416752A (en) 1989-01-20
JP2511293B2 (ja) 1996-06-26
NO167381B (no) 1991-07-22
PH24012A (en) 1990-02-09
FI882836A (sv) 1988-12-17
HUT51232A (en) 1990-04-28

Similar Documents

Publication Publication Date Title
US9517988B2 (en) Phenol derivative and preparation method and use in medicine thereof
KR101465178B1 (ko) 신규 1-아릴-3-아자바이사이클로［3.1.0］헥산：제조 방법 및 신경 정신 질환 치료를 위한 용도
CN101166524B (zh) 氨基酸衍生物
WO1995011894A1 (en) Histamine h3-receptor antagonists and therapeutic uses thereof
US4916151A (en) Method of treating parkinson's syndrome
US20220175700A1 (en) Visual cycle modulators
SU1156593A3 (ru) Способ получени производных бензамида или их кислотно-аддитивных солей,или оптических изомеров
EP1462103A1 (en) NO donors, combination products and uses as modulators of neurotransmitter release
FI86845B (fi) Foerfarande foer framstaellning av en terapeutiskt anvaendbar fluorallylamin.
FI90658B (sv) Förfarande för framställning av terapeutiskt användbar (E)-2-(p-fluorfenetyl)-3-fluorallylamin
JP2758502B2 (ja) （−）−リトドリン
BRPI0812919B1 (pt) composição farmacêutica que compreende um composto e kit
WO2019096113A1 (zh) 一种氘代的含硼的化合物及药物组合物和用途
NO170580B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater
AU2001285894B2 (en) Prodrugs to NMDA receptor ligands
EP2420237A1 (en) Fluorinated derivatives of endogenous isoquinolines for use in the treatment of diseases mediated through endogenous isoquinoline pathways
Rudd et al. Coenzyme-substrate adducts as inhibitors of mouse liver 3, 4-dihydroxyphenylalanine decarboxylase
EP0224924B1 (en) Non-aromatic fluorallylamine mao inhibitors
EP2878592B1 (en) Synthesis of amide derivatives of some nonsteroidal antiinflammatory drugs as potential pro-drugs
MXPA99009120A (es) (s)2-metilamino-2-fenil-n-butil 3,4,5,-trimetoxibenzoato, sus aplicaciones para el tratamiento del dolor cronico.
EP1511728B1 (fr) Derives d oxophenyl-cyclohexyl-propanolamine, leur preparati on et leur application en therapeutique
CZ658590A3 (en) Aminopyridinylmethanols, aminomethylpyridinamines and their derivatives, process of their preparation, pharmaceutical composition containing such compounds and use thereof
FR2745572A1 (fr) Nouveaux sulfonamides derives de benzylamines, leurs sels, ainsi que leurs procedes de fabrication, les compositions pharmaceutiques et leur utilisation comme medicaments
US20090182016A1 (en) Optical enantiomers of phenyramidol and process for chiral synthesis
TWI522358B (zh) 四氫咪唑并〔１，５－ａ〕吡衍生物的鹽，其製備方法及其在醫藥上的應用

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: MERRELL DOW PHARMACEUTICALS INC.